Regulatory milestone strengthens Australia’s sovereign advanced therapeutics manufacturing capability

Viral Vector Manufacturing Facility (VVMF), Australia’s first viral vector Contract Development and Manufacturing ...

September 11, 2026 | Friday | News
Novo Holdings invests in China's ForYou Medical to support advanced wound care manufacturing

Novo Holdings, a leading global healthcare and life sciences investor, has announced a strategic minority investment in ...

September 11, 2026 | Friday | News
Bracco expands BubbleGen cell selection platform with CD3+ T-cell isolation kit

Bracco Imaging has expanded its BubbleGen cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selectio...

September 10, 2026 | Thursday | News
Japan's Hodogaya Chemical sets up Nucleic Acid CDMO subsidiary

Japan-based Hodogaya Chemical has established a subsidiary to promote the nucleic acid therapeutics CDMO business. In it...

September 9, 2026 | Wednesday | News
Samsung Bioepis gains marketing approval in Japan for 130mg intravenous infusion of Ustekinumab Biosimilar

South Korea-based Samsung Bioepis has announced the marketing approval of Ustekinumab BS Intravenous Infusion 130mg...

September 3, 2026 | Thursday | News
Korea's Samsung Biologics announces approx $2 B rights offering to fund next-phase expansion

South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has anno...

August 28, 2026 | Friday | News
First patient dosed in Australian KOALA CAR-T trial for multiple myeloma

Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, a first-in-human study evaluat...

August 27, 2026 | Thursday | News
Strides receives USFDA EIR for Bengaluru manufacturing facility

Strides Pharma Science has received an Establishment Inspection Report from the United States Food and Drug Administrati...

August 20, 2026 | Thursday | News
Linesight’s Stephanie Ledwidge on reducing delivery risk in APAC life sciences projects

Asia-Pacific continues to attract investment across pharmaceutical manufacturing, biotechnology, vaccines, advanced ther...

August 17, 2026 | Monday | Opinion
China's AsymBio secures $184 M capital injection to support long-term growth

AsymBio, a China-based biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of ...

August 5, 2026 | Wednesday | News
AsymBio kicks off construction of R&D building in China for biologics services

AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymche...

July 29, 2026 | Wednesday | News
Korea's GCCL and GemPharmatech sign MoU to advance global drug discovery and development services

GCCL, a South Korea-based leading provider of clinical trial sample analysis, and China & US based GemPharmatech, a ...

July 24, 2026 | Friday | News
Korea's Samsung Biologics buys PolyPeptide for CHF 1.46 B

South Korea-based Samsung Biologics has announced the launch of an all-cash public tender offer to acquire 100% of the f...

July 20, 2026 | Monday | News
Innovent licenses Phase 2-ready anti-CD40L antibody to Spero

Innovent Biologics and Spero Therapeutics have entered into an exclusive licence agreement for IBI355, also known as SP0...

July 20, 2026 | Monday | News
Japan's DNP to acquire Kyowa Pharma Chemical in CDMO expansion

Japan-based Dai Nippon Printing (DNP) has signed a share purchase agreement to acquire Kyowa Pharma Chemical, an act...

July 17, 2026 | Friday | Company results
The CDMO Scale Race Is Over. The Integration Race Has Begun

The global CDMO market is moving beyond the era when manufacturing capacity alone defined competitive ...

July 16, 2026 | Thursday | Influencers
Autolomous and Cellular Origins expand platform integration for cell therapy manufacturing

Autolomous and Cellular Origins have announced end-to-end integration of their respective platforms, bringing full autom...

July 9, 2026 | Thursday | News
RoosterBio, Qkine partner to support stem cell and exosome therapy development

RoosterBio and Qkine have entered a distribution agreement to provide U.S. customers with a single-source platform for c...

July 8, 2026 | Wednesday | News
Catalent, Nanoscope expand partnership for optogenetic gene therapy supply

Catalent and Nanoscope Therapeutics have expanded their partnership to support late-phase clinical development and comme...

July 8, 2026 | Wednesday | News
Matica Bio, VaxDome partner on antigen-agnostic antiviral-vaccine hybrids

Matica Biotechnology has entered a partnership with VaxDome to support development of antigen-agnostic antiviral-vaccine...

July 6, 2026 | Monday | News
The ADC Opportunity Is Expanding—So Are the Demands on Development Partners

As antibody-drug conjugates (ADCs) transition from a promising therapeutic modality to a cornerstone of precision oncolo...

July 6, 2026 | Monday | Influencers
Scaling Smarter: The New Blueprint for Next-Generation ADC Development

ADCs continue to represent a major growth area for drug developers, with the market projected to reach $69B by 20291. As...

July 5, 2026 | Sunday | Influencers
Cryoport to support Verismo’s clinical KIR-CAR T cell therapy programmes

Cryoport’s IntegriCell cryopreservation services have been selected by Verismo Therapeutics to support the company...

June 26, 2026 | Friday | News
Palmer Holland partners FerrinX to distribute precision-fermented lactoferrin

Palmer Holland has partnered with FerrinX to distribute NanoFerrin, a precision-fermented form of lactoferrin for skinca...

June 24, 2026 | Wednesday | News
Sartorius strengthens collaboration with LFB Biomanufacturing

Sartorius and LFB Biomanufacturing have announced an expansion of their collaboration with the aim of offering biop...

June 23, 2026 | Tuesday | News